Tirzepatide (CAS 2023788-19-2) 99.0%
NutraJagen Tirzepatide (CAS 2023788-19-2) is a premium ingredient factory-supplied directly for high-standard global formulation requirements.
🧪 Technical Specs: Tirzepatide / CAS 2023788-19-2 | White to Off-White Lyophilized Powder | Assay ≥99.0% (HPLC).
📦 MOQ & Packaging: Min Order 0.01Kg | Standard 1Kg/Drum or Tailored Custom Packaging.
🌍 Global Compliance: Certified by ISO22000, HACCP, and HALAL to meet stringent international audits.
⚡ Supply Capacity: Factory-direct stable bulk supply. Active Stocks: 10Kg–20Kg available for immediate dispatch. Full COA/MSDS ready.
*Storage Notice: Store in tightly closed original container, protected from light. Free laboratory pilot samples available.
Tirzepatide (CAS 2023788-19-2) ≥99.0% High Purity Peptide
Product Introduction
Tirzepatide (CAS 2023788-19-2) represents a synthetically engineered 39-amino-acid peptide sequence featuring a C20 fatty diacid diacyl moiety that functions as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor co-agonist. Industrial pharmaceutical buyers frequently face batch variance in peptide synthesis, resulting in truncated peptide sequences or residual TFA contamination. Our advanced solid-phase peptide synthesis (SPPS) combined with continuous preparative RP-HPLC purifications yields a uniform purity standard exceeding 99.0% with total residual trifluoroacetic acid held strictly below 0.5%. Formulators integrate this high-purity raw material into advanced metabolic research platforms, targeted lipid management formulations, and subcutaneous delivery systems. Structural stability remains optimal under controlled pH conditions. Delivering zero-defect batch reproducibility provides global pharmaceutical clients and formulation developers with uncompromised analytical integrity, accelerated project timelines, and superior commercial scalability.
Core Functionality & Targeted Applications
Core Health & Biological Functionality:
Dual receptor engagement drives synergistic metabolic regulation. Binding GIP receptors stimulates glucose-dependent insulin secretion while enhancing pancreatic beta-cell survivability and adipocyte lipid buffering. Concurrently, activation of GLP-1 receptors delays gastric emptying rate, suppresses postprandial glucagon secretion, and signals central satiety pathways within the hypothalamus. Pharmacokinetic evaluations show the attached C20 fatty diacid chain promotes high affinity albumin binding. Albumin complexation extends metabolic half-life to approximately 5 days in human models, enabling sustained systemic exposure. Secondary metabolic markers demonstrate marked reductions in intrahepatic triglyceride accumulation and improved peripheral insulin sensitivity across skeletal muscle tissue.
Targeted Industry Applications:
- Metabolic Disease Research Formulations: Utilized in experimental models evaluating glycemic control mechanisms and beta-cell preservation therapies.
- Advanced Weight Management Preparations: Formulated into specialized therapeutic protocols targeted at body composition optimization and visceral fat reduction.
- Subcutaneous Injectable Liquid Delivery Systems: Integrated into sterile buffered aqueous solutions designed for sustained peptide release profiles.
- Endocrine & Lipid Metabolic Assays: Applied as a reference standard in diagnostic panels testing dual incretin signaling pathways and hepatic steatosis biomarkers.
Technical Data Sheet (TDS) & Processing Parameters
| Parameter | Specification Standard | Testing Method |
|---|---|---|
| Chemical Name / INCI | Tirzepatide / Dual GIP/GLP-1 Receptor Agonist Peptide | IUPAC Identification |
| CAS Number | 2023788-19-2 | Chemical Registry Index |
| Appearance | White to Off-White Lyophilized Powder | Visual Inspection |
| Assay (Chromatographic Purity) | ≥ 99.0% (Single Impurity ≤ 0.5%) | RP-HPLC |
| Molecular Weight (MW) | 4813.52 ± 1.0 Da | ESI-MS / LC-MS |
| Heavy Metals (Total) | ≤ 10 ppm (Pb ≤ 2ppm, As ≤ 1ppm, Cd ≤ 1ppm, Hg ≤ 0.1ppm) | ICP-MS |
| Residual Solvents & Counterions | Acetonitrile ≤ 410 ppm; Acetate ≤ 10.0%; TFA ≤ 0.5% | GC-Headspace / IC |
| Bacterial Endotoxins & Bioburden | Endotoxins < 5 EU/mg; Total Microbial Count ≤ 100 cfu/g | LAL Assay / USP <61> |
| Commercial Packaging | 100g/Aluminum Foil Bag; 1kg/Vacuum Sealed Container; 25kg/Drum | Export Sealed Standard Packaging |
| Shelf Life | 24 Months Stored at -20°C Desiccated in Original Unopened Container | Real-Time Stability Testing |
Formulation & Processing Directives
- Recommended Concentration: 2.5 mg/mL to 15 mg/mL in sterile aqueous isotonic vehicle systems depending on dosage targets.
- Thermal Stability Profile: Lyophilized powder resists brief thermal exposure up to 37°C. Reconstituted aqueous solutions degrade rapidly above 25°C and require continuous cold storage (2°C–8°C).
- Optimal pH Stability Window: Maximum chemical stability occurs between pH 7.0 and pH 7.5 in phosphate or citrate buffered systems. Extreme acidic environments (pH < 4.5) induce peptide hydrolysis and precipitation.
- Handling Protocol: Reconstitute using sterile bacteriostatic water under laminar airflow conditions. Avoid vigorous vortexing or sonication to prevent mechanical peptide denaturation and aggregation.
Global Logistics & Matrix Distribution
| Shipping Method | Suited Volume & Freight Cost | Logistics Service Details |
|---|---|---|
| Express Cold-Chain (DHL/FedEx) | Ideal for <50 kg | Higher Cost Per Kg | Door-to-door temperature-monitored transit within 2 to 3 business days. Packaged in insulated containers with gel ice packs to ensure structural stability. |
| Temperature-Controlled Air Freight | Optimal for >50 kg | Moderate Cost | Airport-to-airport transit within 3 to 5 business days. Managed via active cold-storage airport holds with expedited customs clearing documentation. |
| Refrigerated Sea Freight (Reefer Container) | Preferred for >500 kg | Highly Economical | Seaport-to-seaport delivery taking 5 to 7 days for regional oceanic routes. Continuous power monitoring maintains container internal climate at 2°C–8°C or -20°C. |
Technical Capabilities & Commercial Advantages
NutraJagen brings more than 15 years of expertise in astaxanthin manufacturing and global supply, expanding technical synthesis platforms with a broad portfolio covering thousands of plant extract ingredients and specialized bio-active peptides. Proprietary purification technology mitigates residual solvent carryover while standardizing optical purity, guaranteeing repeatable formulation behavior across commercial scale-ups.
Natural Solutions: Focus on plant-based ingredients aligned with clean, sustainable, and health-oriented international concepts.
Quality Management: In-house testing facility combined with independent third-party verification to ensure consistent batch compliance.
Professional Team: Skilled commercial and technical teams providing proactive guidance and responsive R&D support.
Customer Support: End-to-end service team maintaining close follow-up from inquiry to delivery and beyond to ensure seamless cooperation.
Frequently Asked Questions
What is the minimum order quantity (MOQ) for Tirzepatide bulk powder?
Commercial bulk orders start at 0.01 kg sealed in a climate-controlled aluminum foil bag. Analytical laboratory test quantities (1g) are available for corporate evaluations.
What lead times apply to large-scale commercial orders?
Active inventory stocks (10kg–20kg) dispatch within 3 to 5 business days. Contract synthesis campaigns require 10 to 14 business days from formal purchase order receipt.
How is peptide stability ensured during long-distance international transport?
Powders are double-vacuum sealed in moisture-proof aluminum foil and shipped inside insulated temperature-controlled cold-chain packaging containing gel refrigerants.
What technical compliance reports accompany each bulk shipment?
Every lot includes a comprehensive Certificate of Analysis (COA) containing HPLC purity profiles, LC-MS molecular mass confirmation, bacterial endotoxin results, TDS, and Safety Data Sheets (MSDS).
Can NutraJagen supply customized peptide solutions or sterile vial filling?
Yes, custom buffer reconstitutions, tailored lyophilization parameters, and specific vial filling configurations are manufactured based on OEM technical project requirements.
Request Bulk Quotation & Technical Documentation
Access factory-direct volume pricing, batch COAs, and technical evaluation samples. Our technical sales team responds within 12 business hours.
Inquire via Email
We would love to speak with you.
Feel free to reach out using the below details.